Аннотация
Background: Hepatorenal syndrome (HRS) plays an important role in patients with liver cirrhosis before liver transplantation. To determine the dynamics of the severity of the condition and prediction of the estimated risk of mortality (ERM) patients with HRS using cellular mediators.